Ann Rheum Dis July 2022 PMID 35580976

Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials.

Ian N Bruce, Richard A Furie, Eric F Morand, Susan Manzi, Yoshiya Tanaka, Kenneth C Kalunian, Joan T Merrill, Patricia Puzio, Emmanuelle Maho, Christi Kleoudis, Marius Albulescu, Micki Hultquist, Raj Tummala

Download social card

Mentions

5
Peak: 3 in Jun 2022
across 3 sources since Jun 2022

Extended reach

15,346
potential audience

Total likes

11

Video views

1,493

Mentions per month

Jun 2022

All 3 dated mentions so far are from Jun 2022.

Where it's discussed

  • X / Twitter2 posts
  • News2 articles
  • YouTube1 videos

AI synopsis

What people are saying

The discussions mainly revolve around promoting the article through phrases like 'Watch our video,' indicating moderate engagement and interest. The tone is neutral and informational, with little critical analysis or debate, which leads to balanced scores across agreement and impact.

AgreementNeither agree nor disagree

Most discussions simply reference the article, showing neutral feelings with neither strong agreement nor disagreement.

InterestModerate interest

Moderate interest is indicated by the calls to watch the video abstract, suggesting curiosity but limited deeper engagement.

EngagementNeutral engagement

Posts are mostly surface-level, sharing the publication link or video without detailed analysis.

ImpactModerate impact

The discussions acknowledge the importance of the study, but they do not indicate widespread influence or controversy within the community.

Top posts

Most liked on X and Bluesky
Annals of the Rheumatic Diseases
@eular_ARD · X

Concordance and discordance in SLE clinical trial outcome measures: analysis of 3 anifrolumab phase 2/3 trials Watch our video abstract: https://t.co/l1JNsHGl8m

Jun 14, 2022 · 6 likes · 1 share · 13,127 followers View post →
Dalila
@dalilatm · X

RT @ARD_BMJ: Concordance and discordance in SLE clinical trial outcome measures: analysis of 3 anifrolumab phase 2/3 trials Watch our video…

Jun 15, 2022 · 1 share · 723 followers View post →

All mentions

Dalila
@dalilatm · X

RT @ARD_BMJ: Concordance and discordance in SLE clinical trial outcome measures: analysis of 3 anifrolumab phase 2/3 trials Watch our video…

Jun 15, 2022 · 1 share · 723 followers View post →
Annals of the Rheumatic Diseases
@eular_ARD · X

Concordance and discordance in SLE clinical trial outcome measures: analysis of 3 anifrolumab phase 2/3 trials Watch our video abstract: https://t.co/l1JNsHGl8m

Jun 14, 2022 · 6 likes · 1 share · 13,127 followers View post →